Targeted imaging of human endothelial-specific marker in a model of adoptive cell transfer
58114 3700421.pdf (4.284Mb)
Access StatusFull text of the requested work is not available in DASH at this time ("dark deposit"). For more information on dark deposits, see our FAQ.
Kang, Hye Won
Bogdanov, Alexei A.
MetadataShow full item record
CitationKang, Hye Won, Denise Torres, Lawrence Wald, Ralph Weissleder, and Alexei A Bogdanov. 2006. “Targeted Imaging of Human Endothelial-Specific Marker in a Model of Adoptive Cell Transfer.” Laboratory Investigation 86 (6): 599–609. https://doi.org/10.1038/labinvest.3700421.
AbstractImaging of endothelial-specific markers is critically important in non-invasive detection of early signs of vascular pathologies (eg inflammation, atherosclerosis and angiogenesis). A model of adoptive human endothelial cell ( HUVEC) transfer was used to test-specific imaging probes for human vascular disease consisting of cross-linked iron oxide (CLIO) nanoparticles conjugated to anti-human E-selectin (CLIO-F(ab')(2)). To perform in vivo imaging of E-selectin expression in functional blood vessels, human vascular endothelium cells (HUVECs) were implanted in athymic mice in Matrigel solution, which served as a temporary neovascularization scaffold after the solidification. The formation of HUVEC-containing vessels was established by histology and microscopy. CLIO-F(ab')(2) probes were administered via an i.v. injection following the induction of E-selectin expression by IL-1 beta. High-resolution MR images were obtained before and after the administration of CLIO-F(ab')(2), which showed specific hypointensity only if treated with IL-1 beta. A three-times higher CLIO-induced MR signal decrease on T2* images was measured in HUVEC implants in response to IL-1 beta treatment. Image signal intensity did not change in control animals that: (1) harbored Matrigel alone, (2) in the absence of IL-1 beta treatment or (3) in animals injected with CLIO linked to the idiotype-matched control F(ab')(2). Experiments in an adoptive transfer model demonstrated that HUVEC-containing neovessels are perfused and that IL-1 beta inducible E-selectin expression in these vessels is detectable with non-invasive imaging by using targeted nanoparticles.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:41384386
- HMS Scholarly Articles